Locations
Ontario, Canada · Toronto, ON, Canada · Old Toronto, Toronto, ON, Canada · North York, Toronto, ON, Canada
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2019
CTRL Therapeutics is a biotechnology company focused on developing innovative cell therapies for solid tumors, leveraging a unique circulating T cell population known as c TRLs. Their proprietary platform, Iso Qore™, allows for efficient extraction and isolation of these cells from a simple blood draw, addressing the challenges faced in traditional solid tumor treatments. By eliminating the need for invasive surgical procedures and simplifying the complexities of therapy development, CTRL Therapeutics aims to redefine the landscape of cancer treatment, targeting the 90% of cancers that are solid tumors.
Something looks off?On-site & Remote